Related Experiment Video
Updated: Jan 29, 2026

Isolation and Genetic Manipulation of Adult Cardiac Myocytes for Confocal Imaging
Published on: September 17, 2009
Gene Transfer of Calcium-Binding Proteins into Adult Cardiac Myocytes
Brian R Thompson1, Houda Cohen1, Addeli Bez Batti Angulski1
1Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USA.
Insights
Researchers explored using parvalbumin gene transfer to improve calcium handling in heart failure. This therapeutic approach aims to restore normal heart muscle function by enhancing calcium buffering in cardiac myocytes.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Heart failure is a leading cause of death, with diastolic heart failure comprising 50% of cases.
- Diastolic heart failure is characterized by impaired myocardial relaxation and left ventricular filling.
- Calcium-handling dysregulation is a key factor contributing to diastolic heart failure.
Purpose of the Study:
- To investigate novel human calcium (Ca2+) binding protein motifs for restoring normal Ca2+ handling in diseased myocardium.
- To evaluate gene transfer of parvalbumin as a potential therapeutic strategy for diastolic heart failure.
- To provide protocols for studying parvalbumin function in adult cardiac myocytes.
Main Methods:
- Utilizing gene transfer of parvalbumin into adult cardiac myocytes.
- Employing acute adenoviral gene transfer to deliver parvalbumin.
- Studying wild-type parvalbumin isoforms and engineered parvalbumins with specific EF-hand motifs.
Main Results:
- Parvalbumin acts as a strategic Ca2+ buffer to correct cardiac mechanical dysfunction.
- Adenoviral gene transfer protocols were established for studying parvalbumin in cardiac myocytes.
- Optimization of parvalbumin function for therapeutic applications in heart failure was pursued.
Conclusions:
- Gene transfer of parvalbumin shows potential as a therapeutic for heart failure by addressing calcium-handling deficits.
- Engineered parvalbumin motifs may offer enhanced therapeutic benefits.
- The described protocols facilitate the development of parvalbumin-based therapies for failing heart muscle.
Abstract:
Heart failure is the leading cause of combined morbidity and mortality in the USA with 50% of cases being diastolic heart failure. Diastolic heart failure results from poor myocardial relaxation and inadequate filling of the left ventricular chamber caused in part by calcium-handling dysregulation. In this chapter we describe methods to investigate new approaches of novel human Ca2+ binding protein motifs to restore normal Ca2+ handling function to diseased myocardium. Gene transfer of parvalbumin into adult cardiac myocytes has been studied as a potential therapeutic, specifically as a strategic Ca2+ buffer to correct cardiac mechanical dysfunction in disease. This chapter provides protocols for studying wild-type parvalbumin isoforms and parvalbumins with strategically designed EF-hand motifs in adult cardiac myocytes via acute adenoviral gene transfer. These protocols have been used extensively to optimize parvalbumin function as a potential therapeutic for failing heart muscle.
Related Concept Videos
Horizontal Gene Transfer
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...
Proteins: From Genes to Degradation
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The Equilibrium Binding Constant and Binding Strength
Drug Distribution: Plasma Protein Binding

